* Industry diversification based on Moody's industry classification. Measured as the fair value of investments for each category against the total fair value of all investments. Totals may not sum due to rounding.
A balanced portfolio built on the cornerstones of diversification and selectivity
Anchored in senior secured loans, NCDL has built a scaled and diversified portfolio by industry, investment type and portfolio company. Selectivity, diversification and rigorous underwriting are key to our investment philosophy, enabling strong credit performance since inception.
$2.1B
Investment portfolio at fair value1
91%
First-lien term loans2
210
Portfolio companies
0.5%
Average position size
$76M
Weight average annual EBITDA3
Portfolio holdings
Top ten positions
Lead Left Arranger
Senior Secured Credit Facility
2022
Lead Left Arranger
Unitranche Credit Facility
2022
Sole Lead Arranger
Senior Secured Credit Facility
2023
Lead Left Arranger
First Lien Credit Facility
2022
Lender
Unitranche Credit Facility
2019
Lead Left Arranger
Senior Secured Credit Facility
2024
Co-Lead Arranger
Senior Secured Credit Facility
Equity
2020
Sole Lead Arranger
Senior Secured Credit Facility
2024
Lead Left Arranger
Senior Secured Credit Facility
2024
Lead Left Arranger
Senior Secured Credit Facility
2022
Represents the top ten positions in NCDL based on Fair Value as of March 31, 2025
| Company | Fair value ($ in thousands) | Industry | Asset Types | Pricing1 |
|---|---|---|---|---|
| GHR Healthcare, LLC | (22,765) | Healthcare & Pharmaceuticals | First Lien Debt (Delayed Draw) | S + 5.25% |
| YI, LLC (Young Innovations) | (44,828) | Healthcare & Pharmaceuticals | First Lien Debt (Delayed Draw) | S + 5.75% |
| Genesee Scientific LLC | 1,338,576 | Healthcare & Pharmaceuticals | First Lien Debt (Delayed Draw) | S + 5.75% |
| FH DMI Buyer, Inc. | 194,325 | Healthcare & Pharmaceuticals | First Lien Debt (Delayed Draw) | S + 5.00% |
| ISG Enterprises, LLC (Industrial Service Group) | 3,297,496 | Wholesale | First Lien Debt (Delayed Draw) | S + 5.75% |
| ACP Maverick Holdings, Inc. | (35,932) | Healthcare & Pharmaceuticals | First Lien Debt (Delayed Draw) | S + 4.75% |
| CLS Management Services, LLC (Contract Land Staff) | (43,990) | Environmental Industries | First Lien Debt (Delayed Draw) | S + 5.00% |
| Impact Parent Corporation (Impact Environmental Group) | 3,105,008 | Environmental Industries | First Lien Debt (Delayed Draw) | S + 5.25% |
| CLS Management Services, LLC (Contract Land Staff) | 2,983,827 | Environmental Industries | First Lien Debt (Delayed Draw) | S + 5.00% |
| US MetalCo Holdings LLC (MGM Transformer Company) | 6,358,239 | Energy: Electricity | First Lien Debt (Delayed Draw) | S + 5.50% |
| Matador US Buyer, LLC (Insulation Technology Group) | 5,558,227 | Energy: Electricity | First Lien Debt (Delayed Draw) | S + 5.00% |
| Revalize Inc. (f/k/a AQ Holdco Inc.) | 3,294,725 | High Tech Industries | First Lien Debt (Delayed Draw) | S + 5.75% |
| Impact Parent Corporation (Impact Environmental Group) | 6,729,942 | Environmental Industries | First Lien Debt (Delayed Draw) | S + 5.25% |
| NFM & J, L.P. (The Facilities Group) | 4,863,584 | Environmental Industries | First Lien Debt (Delayed Draw) | S + 5.75% |
| SI Solutions, LLC | 6,721 | Environmental Industries | First Lien Debt (Delayed Draw) | S + 4.75% |
| AB Centers Acquisition Corporation (Action Behavior Centers) | 924,564 | Healthcare & Pharmaceuticals | First Lien Debt (Delayed Draw) | S + 5.00% |
| Orion Group FM Holdings, LLC (Leo Facilities) | (45,717) | Environmental Industries | First Lien Debt (Delayed Draw) | S + 5.50% |
| Orion Group FM Holdings, LLC (Leo Facilities) | 4,699,728 | Environmental Industries | First Lien Debt (Delayed Draw) | S + 5.50% |
| NFM & J, L.P. (The Facilities Group) | 532,842 | Environmental Industries | First Lien Debt (Delayed Draw) | S + 5.75% |
| Health Management Associates, Inc. | 1,063,441 | Healthcare & Pharmaceuticals | First Lien Debt (Delayed Draw) | S + 6.25% |
| GHR Healthcare, LLC | 1,907,407 | Healthcare & Pharmaceuticals | First Lien Debt (Delayed Draw) | S + 5.25% |
| Promptcare Infusion Buyer, Inc. | 1,426,566 | Healthcare & Pharmaceuticals | First Lien Debt (Delayed Draw) | S + 6.00% |
| Wellspring Pharmaceutical Corporation | 2,548,642 | Healthcare & Pharmaceuticals | First Lien Debt (Delayed Draw) | S + 5.00% |
| Lavie Group, Inc. | (7,317) | Healthcare & Pharmaceuticals | First Lien Debt (Delayed Draw) | S + 5.25% |
| QHR Health, LLC | 3,206,880 | Healthcare & Pharmaceuticals | First Lien Debt (Delayed Draw) | S + 5.25% |
| Wellspring Pharmaceutical Corporation | 1,549,075 | Healthcare & Pharmaceuticals | First Lien Debt (Delayed Draw) | S + 5.00% |
| TBRS, Inc. | (21,431) | Healthcare & Pharmaceuticals | First Lien Debt (Delayed Draw) | S + 4.75% |
| Tidi Legacy Products, Inc. | 33,465 | Healthcare & Pharmaceuticals | First Lien Debt (Delayed Draw) | S + 5.25% |
| Impact Advisors, LLC | (70,776) | Healthcare & Pharmaceuticals | First Lien Debt (Delayed Draw) | S + 4.75% |
| JKC Buyer, Inc. (J. Knipper and Company Inc) | (20,140) | Healthcare & Pharmaceuticals | First Lien Debt (Delayed Draw) | S + 5.00% |
1. The majority of the investments bear interest at rates that may be determined by reference to Secured Overnight Financing Rate ("SOFR" or "S"), which reset monthly or quarterly. For each such investment, the Company has provided the spread over SOFR and the current contractual interest rate in effect at March 31, 2025. As of March 31, 2025, rates for 1M S, 3M S, 6M S, 12M S ("SOFR") are 4.32%, 4.29%, 4.19%, and 4.01% respectively. Certain investments are subject to a SOFR floor or may utilize an alternative reference rate such as U.S. Prime Rate (“P”). For fixed rate loans, a spread above a reference rate is not applicable.